These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35114010)
1. Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations. Ziemssen T; Akgun K; Członkowska A; Antos A; Bembenek J; Kurkowska-Jastrzębska I; Przybyłkowski A; Skowrońska M; Smolinski L; Litwin T Mov Disord; 2022 May; 37(5):1074-1079. PubMed ID: 35114010 [TBL] [Abstract][Full Text] [Related]
2. Serum Neurofilament Light Chain in Wilson's Disease: A Promising Indicator but Unparallel to Real-Time Treatment Response. Wang RM; Xu WQ; Zheng ZW; Yang GM; Zhang MY; Ke HZ; Xia N; Dong Y; Wu ZY Mov Disord; 2022 Jul; 37(7):1531-1535. PubMed ID: 35507442 [TBL] [Abstract][Full Text] [Related]
3. Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson's disease. Ziemssen T; Smolinski L; Członkowska A; Akgun K; Antos A; Bembenek J; Kurkowska-Jastrzębska I; Przybyłkowski A; Skowrońska M; Redzia-Ogrodnik B; Litwin T Acta Neurol Belg; 2023 Jun; 123(3):917-925. PubMed ID: 36098934 [TBL] [Abstract][Full Text] [Related]
4. Brain Atrophy Is Substantially Accelerated in Neurological Wilson's Disease: A Longitudinal Study. Smolinski L; Ziemssen T; Akgun K; Antos A; Skowrońska M; Kurkowska-Jastrzębska I; Członkowska A; Litwin T Mov Disord; 2022 Dec; 37(12):2446-2451. PubMed ID: 36165286 [TBL] [Abstract][Full Text] [Related]
5. Plasma neurofilament light chain as a biomarker in Wilson's disease. Yang J; Huang Z; Yang H; Luo Y; You H; Chen D; Pei Z; Li X Parkinsonism Relat Disord; 2022 Feb; 95():5-10. PubMed ID: 34942565 [TBL] [Abstract][Full Text] [Related]
6. Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease. Shribman S; Heller C; Burrows M; Heslegrave A; Swift I; Foiani MS; Gillett GT; Tsochatzis EA; Rowe JB; Gerhard A; Butler CR; Masellis M; Bremner F; Martin A; Jung L; Cook P; Zetterberg H; Bandmann O; Rohrer JD; Warner TT Mov Disord; 2021 Feb; 36(2):503-508. PubMed ID: 33078859 [TBL] [Abstract][Full Text] [Related]
7. Neuroimaging correlates of brain injury in Wilson's disease: a multimodal, whole-brain MRI study. Shribman S; Bocchetta M; Sudre CH; Acosta-Cabronero J; Burrows M; Cook P; Thomas DL; Gillett GT; Tsochatzis EA; Bandmann O; Rohrer JD; Warner TT Brain; 2022 Mar; 145(1):263-275. PubMed ID: 34289020 [TBL] [Abstract][Full Text] [Related]
8. Brain magnetic resonance imaging and severity of neurological disease in Wilson's disease - the neuroradiological correlations. Rędzia-Ogrodnik B; Członkowska A; Bembenek J; Antos A; Kurkowska-Jastrzębska I; Skowrońska M; Smoliński Ł; Litwin T Neurol Sci; 2022 Jul; 43(7):4405-4412. PubMed ID: 35275318 [TBL] [Abstract][Full Text] [Related]
9. Brain volume is related to neurological impairment and to copper overload in Wilson's disease. Smolinski L; Litwin T; Redzia-Ogrodnik B; Dziezyc K; Kurkowska-Jastrzebska I; Czlonkowska A Neurol Sci; 2019 Oct; 40(10):2089-2095. PubMed ID: 31147855 [TBL] [Abstract][Full Text] [Related]
10. Quantitative Measurement of Metal Accumulation in Brain of Patients With Wilson's Disease. Li G; Wu R; Tong R; Bo B; Zhao Y; Gillen KM; Spincemaille P; Ku Y; Du Y; Wang Y; Wang X; Li J Mov Disord; 2020 Oct; 35(10):1787-1795. PubMed ID: 32681698 [TBL] [Abstract][Full Text] [Related]
11. Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease. Shribman S; Burrows M; Convery R; Bocchetta M; Sudre CH; Acosta-Cabronero J; Thomas DL; Gillett GT; Tsochatzis EA; Bandmann O; Rohrer JD; Warner TT Mov Disord; 2022 Aug; 37(8):1728-1738. PubMed ID: 35723521 [TBL] [Abstract][Full Text] [Related]
12. Altered large-scale functional brain networks in neurological Wilson's disease. Jing R; Han Y; Cheng H; Han Y; Wang K; Weintraub D; Fan Y Brain Imaging Behav; 2020 Oct; 14(5):1445-1455. PubMed ID: 31011947 [TBL] [Abstract][Full Text] [Related]